| Durability of SARS-CoV-2–specific T-cell responses at 12 months postinfection Z Lu, ED Laing, J Pena DaMata, K Pohida, MS Tso, EC Samuels, NJ Epsi, ... The Journal of Infectious Diseases 224 (12), 2010-2019, 2021 | 38 | 2021 |
| Broadly effective metabolic and immune recovery with C5 inhibition in CHAPLE disease A Ozen, N Kasap, I Vujkovic-Cvijin, R Apps, F Cheung, E Karakoc-Aydiner, ... Nature immunology 22 (2), 128-139, 2021 | 31 | 2021 |
| Seroprevalence of Baylisascaris procyonis infection among humans, Santa Barbara County, California, USA, 2014–2016 SB Weinstein, CM Lake, HM Chastain, D Fisk, S Handali, PL Kahn, ... Emerging infectious diseases 23 (8), 1397, 2017 | 15 | 2017 |
| TIM-3 drives temporal differences in restimulation-induced cell death sensitivity in effector CD8+ T cells in conjunction with CEACAM1 CM Lake, K Voss, BM Bauman, K Pohida, T Jiang, G Dveksler, AL Snow Cell Death & Disease 12 (4), 400, 2021 | 14 | 2021 |
| FOXP3 protects conventional human T cells from premature restimulation-induced cell death K Voss, C Lake, CR Luthers, NM Lott, B Dorjbal, S Arjunaraja, ... Cellular & Molecular Immunology 18 (1), 194-205, 2021 | 12 | 2021 |
| Sequence similarity between SARS-CoV-2 nucleocapsid and multiple sclerosis-associated proteins provides insight into viral neuropathogenesis following infection CM Lake, JJ Breen Scientific Reports 13 (1), 389, 2023 | 7 | 2023 |
| Restimulation-induced cell death (RICD): methods for modeling, investigating, and quantifying RICD sensitivity in primary human T cells via flow cytometric analysis K Pohida, CM Lake, D Yee, AL Snow Bio-protocol 12 (4), e4326-e4326, 2022 | 2 | 2022 |
| Molecular and temporal control of restimulation-induced cell death (RICD) in T lymphocytes KP Lee, B Epstein, CM Lake, AL Snow Frontiers in cell death 2, 1281137, 2023 | | 2023 |
| PD-1 protects expanding human T cells from premature restimulation-induced cell death. K Lee, S Elster, CM Lake, AL Snow The Journal of Immunology 210 (1_Supplement), 239.10-239.10, 2023 | | 2023 |
| Sequence similarity between SARS-CoV-2 Nucleocapsid and CNS proteins provides mechanistic insight into viral neuropathogenesis following infection C Lake, J Breen The Journal of Immunology 208 (1_Supplement), 102.11-102.11, 2022 | | 2022 |
| 461. Classical Antigen Presenting Cell Activation Correlates with T Cell Immunity and COVID-19 Severity Z Lu, J Pena-DaMata, K Pohida, C Lake, NJ Epsi, SA Richard, B Agan, ... Open forum infectious diseases 8 (Supplement_1), S333-S333, 2021 | | 2021 |
| Durability of SARS-CoV-2-specific T cell responses at 12-months post-infection (preprint) Z Lu, ED Laing, J Pena-Damata, K Pohida, MS Tso, EC Samuels, NJ Epsi, ... | | 2021 |
| The Influence of Co-Signaling Proteins on Restimulation-Induced Cell Death in Effector T Lymphocytes C Lake Uniformed Services University of the Health Sciences, Bethesda, Maryland 20814, 2021 | | 2021 |
| Broadly effective metabolic and immune recovery with C5 inhibition in A Ozen, N Kasap, I Vujkovic-Cvijin, R Apps, F Cheung, E Karakoc-Aydiner, ... | | 2021 |
| TIM-3-dependent regulation of restimulation-induced cell death sensitivity flips changes in early versus late-stage human effector T cells C Lake, T Jiang, B Bauman, K Voss, AL Snow The Journal of Immunology 202 (1_Supplement), 60.9-60.9, 2019 | | 2019 |
| FOXP3, CD48 and autophagy confer the protection of CD4 and CD8 human T cells from T cell receptor restimulation-induced cell death K Voss, NM Lott, C Lake, BM Bauman, B Dorjbal, CR Luthers, ... The Journal of Immunology 202 (1_Supplement), 184.5-184.5, 2019 | | 2019 |
